| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.29 | 0.02 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.02 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.097 | 0.02 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.13 | 0.02 |